Patients supported by left ventricular-assist devices are at high risk of bleeding, but among the numerous hemorrhagic complications, those involving the corpus callosum are very uncommon. We report the case of a 35-year-old woman who suddenly experienced neurological symptoms 4 months after HeartMate II implantation. Cranial computed tomography showed a voluminous hematoma involving the corpus callosum.
DengMCEdwardsLBHertzMIRoweAWKeckBMKormosR. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report-2005. J Heart Lung Transplant2005; 24: 1182–1187.
2.
KlovaiteJGustafssonFMortensenSASanderKNielsenLB. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol2009; 53: 2162–2167.
3.
HeilmannCGeisenUBeyersdorfFNakamuraLTrummerGBerchtold-HerzM. Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients. Eur J Cardiothorac Surg2011; 40: 11328–11333.
4.
PaeWEConnellJMBoehmerJPKorferREl-BanayosyAHetzerR. Neurologic events with a totally implantable left ventricular assist device: European LionHeart Clinical Utility Baseline Study (CUBS). J Heart Lung Transplant2007; 26: 1–8.
TsukuiHAblaATeutebergJJMcNamaraDMMathierMACadaretLM. Cerebrovascular accidents in patients with a ventricular assist device. J Thorac Cardiovasc Surg2007; 134: 114–123.
7.
JohnRKamdarFLiaoKColvin-AdamsMMillerLJoyceL. Low thromboembolic risk for patients with the HeartMate II left ventricular assist device. J Thorac Cardiovasc Surg2008; 136: 1318–1323.
8.
StrüberMSanderKLahporJAhnHLitzlerPYDrakosSG. HeartMate II left ventricular assist device; early European experience. Eur J Cardiothorac Surg2008; 34: 289–294.
